The FDA has approved a new antibiotic that can treat uncomplicated urinary tract infections, or uUTIs. It’s the first new class of oral antibiotics for UTIs in almost 30 years, according to developer ...

Delayed empiric antibiotics in kidney transplant patients with urosepsis are strongly linked to increased mortality and AKI ...

Swiss pharmaceutical firm Roche has advanced its antibiotic candidate, zosurabalpin, into Phase 3 clinical trials, ...

Sexual activity can increase the risk of urinary tract infections UTIs especially in women An expert explains why sex may ...

A new Rutgers Health study reveals a surprising twist in the antibiotic resistance story: instead of simply killing bacteria, ...

It's usually prescribed to bring relief for a specific type of infection, but officials now say there's a "microbial ...

A new study from Rutgers Health shows that ciprofloxacin, a staple treatment for urinary tract infections, throws Escherichia ...

Tebipenem's approval in 2026 under SPA could bring Spero $400M+ in milestones & royalties. Read more on why SPRO is a Buy, ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has banned an unregistered batch of Tarivid ...

Discover the potential solution to antibiotic resistance with bacteriophages, a natural alternative to combat bacterial ...

The FDA has approved Allecra Therapeutics' Exblifep, a combination antibiotic for complicated urinary tract infections (cUTIs) that will now launch later this year, but turned down a rival product ...

EVERSANA, a leading provider of global commercial services to the life sciences industry, has announced two strategic ...